Kyrgyzstan

Central Asia

Contents

1. Regulatory Overview
2. Regulatory Pathways

Regulatory Overview

Kyrgyzstan is regulated by the Department of Drug Provision. The country has 1 documented regulatory pathway for accessing unapproved or unlicensed medicines, covering named patient programs, compassionate use schemes, and special access arrangements.

Regulatory Authority

Department of Drug Provision

Regulatory Pathways (1)

Kyrgyzstan MOH Special Import Authorization 45 days

Kyrgyzstan Ministry of Health special import authorization for unregistered medicines for patients with serious or life-threatening conditions.

Application Form: MOH Kyrgyzstan Special Import Form

Legal Basis: Regulated

Eligibility: Serious or life-threatening condition with no locally registered alternative

Kyrgyzstan

ISO Code	`KG`
Region	Central Asia
Regulatory Authority	Department of Drug Provision
Pathways	1 documented
Drugs Available	0 documented